New weapon in the fight against Corona:Vaccine made in Europe 100% effective against serious infection, will also work as a booster

 Vaccine is the most important weapon against corona. Scientists around the world are engaged in making such a vaccine that can give us 100% protection from this virus. Two pharma companies in Europe have done this. A new vaccine made by the companies Sanofi and GSK is 100% effective against severe infection of the corona.

Vaccine will be named Vidprevatin

According to a spokesperson for Sanofi, this new vaccine will be named Vidprevatin. Data from clinical trials and booster trials in the US and Europe will soon be submitted for approval.

Good results found in the study

In a separate study, the vaccine was also given as a booster dose.

According to Sanofi and GSK, two doses of this vaccine will be given in an interval of 3 weeks. Its Phase 3 trial was done on 10,000 people from America, Asia, Africa and Latin America. These people did not develop any antibodies against the corona.

These results of the vaccine came out after two doses.

• 58% effective in protecting against corona symptoms
• 75% effective in protecting against moderate to severe corona infection
• 100% effective in preventing serious infection and hospitalization

Vaccines can be mixed and matched

In a separate study, it was also given to people as a booster dose. According to Sanofi and GSK, antibodies against corona increased by 10 to 30 times when giving Vidprevatin vaccine to fully vaccinated people from Pfizer, Moderna, Johnson & Johnson and AstraZeneca.

Vidprevatin vaccine made like this

This vaccine was funded under the Operation Warp Speed ​​of former US President Donald Trump.

Vidprevatin is a protein subunit vaccine. This means that through the harmless proteins of the corona virus, it teaches the human immune system how to fight the virus when it enters the body. It is quite traditional as compared to mRNA vaccine.

Vaccines like Vidprevatin can be easily stored at refrigerator temperature. It is very useful in those places where there is no availability of cold storage.

This vaccine received funding of $ 2.1 billion under former US President Donald Trump's Operation Warp Speed. According to the companies, 100 million doses of Vidprevatin have already been prepared and plans are on to supply 400 million doses.